Jeffrey Smith’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Jeffrey Smith’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41,950	Closed	-$438K	–	103
2023 Q1	$438K	Hold	41,950	–	–	0.01%	105
2022 Q4	$427K	Hold	41,950	–	–	0.01%	148
2022 Q3	$421K	Hold	41,950	–	–	0.01%	174
2022 Q2	$418K	Hold	41,950	–	–	0.01%	180
2022 Q1	$419K	Sell	41,950 -6,150	-13%	-$61K	0.01%	168
2021 Q4	$474K	Buy	+48,100	New	+$476K	0.01%	133

Jeffrey Smith's LVAC Position: Q2 2023 in Review

Jeffrey Smith sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 41,950 shares — an estimated $438K sold.

Jeffrey Smith first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $474K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Jeffrey Smith reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Jeffrey Smith sold 41,950 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $438K.
Jeffrey Smith first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Jeffrey Smith's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $474K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Starboard Value's 13F filing for Q2 2023, filed 11 Aug 2023.